A new treatment at Unity Point Health is offering promising results for those with irregular heartbeats, otherwise known as ...

Research reveals rise in AFib among younger people. Learn the warning signs, risk factors and how to protect your heart ...

Recent research shows the incredible success of radiofrequency ablation in treating AFib, offering renewed hope for patients.

Patients with a common heart rhythm disorder who took an experimental blood-thinning drug had far fewer bleeding episodes ...

Patients with atrial fibrillation are typically prescribed an anticoagulant, or blood thinner, to reduce the risk of stroke, ...

Physicians also expect greater use of Johnson & Johnson’s Varipulse system over the next two years despite the company’s ...

Allina Health Minneapolis Heart Institute first in Minn., Upper Midwest to use new, FDA-approved device to treat persistent ...

As per a survey, only a fraction of smartwatch users share details of their health stats with a doctor, a misstep that could ...

Researchers have found that Factor XI inhibitors, such as abelacimab, reduce bleeding risks in atrial fibrillation patients more effectively than standard anticoagulants.

Researchers evaluated a drug that represents a new class of anticoagulants known as Factor XI inhibitors for treating patients with atrial fibrillation as part of the AZALEA-TIMI 71 Study. The trial ...